THERAKOS CELLEX PHOTOPHERESIS SYSTEM PROCEDURAL KIT
FDA premarket approval P860003/S082 · decided 2016-01-21
Approval details
- PMA number
- P860003
- Supplement
- S082
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- THERAKOS CELLEX PHOTOPHERESIS SYSTEM PROCEDURAL KIT
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 2015-12-24
- Decision date
- 2016-01-21
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- A CHANGE IN THE INSPECTION PROCESS FOR CELLEX PROCEDURAL KIT CARTONS PRIOR TO THEIR PLACEMENT IN THEIR SHIPPING PALLETS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.